Xia-Ying Kuang

578 total citations
9 papers, 442 citations indexed

About

Xia-Ying Kuang is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Xia-Ying Kuang has authored 9 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cancer Research, 3 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Xia-Ying Kuang's work include Breast Cancer Treatment Studies (2 papers), Cancer Genomics and Diagnostics (2 papers) and RNA Research and Splicing (2 papers). Xia-Ying Kuang is often cited by papers focused on Breast Cancer Treatment Studies (2 papers), Cancer Genomics and Diagnostics (2 papers) and RNA Research and Splicing (2 papers). Xia-Ying Kuang collaborates with scholars based in China, Canada and United States. Xia-Ying Kuang's co-authors include Zhi-Ming Shao, Gen‐Hong Di, Xin Hu, Yi‐Rong Liu, Zhi‐Ming Shao, Yang Liu, Feng Qiao, Yi‐Feng Hou, Jiong Wu and Jian-Min Luo and has published in prestigious journals such as Nature Communications, Clinical Cancer Research and RSC Advances.

In The Last Decade

Xia-Ying Kuang

8 papers receiving 441 citations

Peers

Xia-Ying Kuang

MB

CR

ONCOL

PRM

CB

Jingxin Feng China

Reyno Del Rosario United States

Karuna Mittal United States

Jessica C. Price United States

Makoto Nagahara Japan

Ming‐Hsin Yeh Taiwan

Aviva P. Ventura United States

Wijnand Roessingh Netherlands

Robyn T. Sussman United States

Carmen Oi‐Ning Leung Hong Kong

Jingxin Feng China

Xia-Ying Kuang

459 ×1.6

MB

184 ×0.8

CR

198 ×1.8

ONCOL

96 ×1.4

PRM

43 ×0.6

CB

Citations per year, relative to Xia-Ying Kuang Xia-Ying Kuang (= 1×) peers Jingxin Feng

Countries citing papers authored by Xia-Ying Kuang

Since Specialization

Citations

This map shows the geographic impact of Xia-Ying Kuang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xia-Ying Kuang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xia-Ying Kuang more than expected).

Fields of papers citing papers by Xia-Ying Kuang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xia-Ying Kuang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xia-Ying Kuang. The network helps show where Xia-Ying Kuang may publish in the future.

Co-authorship network of co-authors of Xia-Ying Kuang

This figure shows the co-authorship network connecting the top 25 collaborators of Xia-Ying Kuang. A scholar is included among the top collaborators of Xia-Ying Kuang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xia-Ying Kuang. Xia-Ying Kuang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Liu, Mengqi, et al.. (2025). Synthesis and solvatochromism of a NIR II emissive amphiphilic aza-BODIPY dye and its application as a colorimetric and fluorometric probe in sequential detection of Cu ²⁺ and PO ₄ ³⁻. RSC Advances. 15(48). 40730–40736.

2.

Liu, Yang, et al.. (2018). MicroRNA-200a confers chemoresistance by antagonizing TP53INP1 and YAP1 in human breast cancer. BMC Cancer. 18(1). 74–74. 51 indexed citations

3.

Chen, Li, Yang Liu, Ling Yao, et al.. (2018). Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients. Nature Communications. 9(1). 1357–1357. 116 indexed citations

4.

Kuang, Xia-Ying, Yan Xu, Yi-Zi Zheng, et al.. (2016). Androgen receptor expression predicts different clinical outcomes for breast cancer patients stratified by hormone receptor status. Oncotarget. 7(27). 41285–41293. 52 indexed citations

5.

Kuang, Xia-Ying, Kai Li, Yi-Zi Zheng, et al.. (2016). The phosphorylation-specific association of STMN1 with GRP78 promotes breast cancer metastasis. Cancer Letters. 377(1). 87–96. 35 indexed citations

6.

Kuang, Xia-Ying, Li Chen, Zhijie Zhang, et al.. (2015). Stathmin and phospho-stathmin protein signature is associated with survival outcomes of breast cancer patients. Oncotarget. 6(26). 22227–22238. 36 indexed citations

7.

Shao, Zhimin, Kai Li, Ling Yao, et al.. (2014). ID2 predicts poor prognosis in breast cancer, especially in triple-negative breast cancer, and inhibits E-cadherin expression. OncoTargets and Therapy. 7. 1083–1083. 14 indexed citations

8.

Kuang, Xia-Ying, Jian-Min Luo, Yi‐Feng Hou, et al.. (2013). MicroRNA-200a Promotes Anoikis Resistance and Metastasis by Targeting YAP1 in Human Breast Cancer. Clinical Cancer Research. 19(6). 1389–1399. 132 indexed citations

9.

Tumuluru, Jaya Shankar, et al.. (2013). Effect of low and high storage temperatures on headspace gas concentrations and physical properties of wood pellets. International Wood Products Journal. 4(4). 207–216. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact